The Digital Pathology Association (DPA), a non-profit organization committed to the advancement of digital pathology applications, announces the addition of Eric F. Glassy, M.D., and Sylvia L. Asa, M.D., Ph.D.—both practicing pathologists—to its board of directors, adding to the existing roster of influential leaders from the digital pathology industry. The board meets regularly to provide strategic direction and guidance as the DPA accelerates its membership, ongoing programs, and educational focus.
“The DPA is eager to involve more pathology leaders in the organization. The addition of Drs. Glassy and Asa to the DPA’s board of directors is an important step in our ongoing efforts to add leading pathologists with diverse backgrounds and experiences to help guide the rapidly growing number of DPA activities,” commented DPA president, Dirk Soenksen. “Our aim is to have a majority of the board comprised of practicing pathologists, and to work together with industry leaders to shepherd the adoption of digital pathology. The DPA offers leadership opportunities ranging from committee service to board seats to pathologists and other professionals interested in fostering the adoption of digital pathology through education and awareness.”
Eric F. Glassy, M.D., is a board certified Anatomic and Clinical Pathologist. He has served as Laboratory Director for several Southern California hospitals and has served in key leadership roles for hospital staff and foundation committees. He currently serves as a Medical Director at Pathology, Inc. a national reference laboratory and is also currently chairman of the CAP Curriculum Committee. He was recently honored by the CAP with the Pathologists' Distinguished Service Award. He is also a board member of the CAP Foundation. He is a well-known lecturer and has authored several publications in his fields of interest. Dr. Glassy joins the board following years of attendance at the annual Pathology Visions conference, the premier conference on digital pathology, and witnessing the increasing contributions of the DPA. Dr. Glass is also actively involved with the College of American Pathologists (CAP) and observes a clear alignment between the goals of the CAP and the goals of the DPA. “Both organizations see the importance of standard setting. Currently those in the industry look to vendors to provide direction, but standards and best practices need to be created by vendor neutral organizations like CAP and the DPA. The DPA can create cross platform best practice sharing among all those involved in the industry. Sharing best practices will work to validate the contribution of digital pathology as standards are established,” stated Dr. Glassy.
Sylvia L. Asa, MD, Ph.D is a Clinician-Scientist with a focus on endocrine pathology and is the Pathologist-in-Chief and Medical Director of the Laboratory Medicine Program at the University Health Network. She is also a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. As head of the largest pathology department in Canada, Dr. Asa has made innovative changes to the practice of the discipline, with emphasis on sub specialization, automation, electronic initiatives and telepathology. Dr. Asa has published many articles, books and chapters. She has been the recipient of several prestigious awards for her contributions and most recently earned the William Boyd Lecture Award of the Canadian Association of Pathologists (2010.) To ensure public knowledge of the role of Pathology and maintain a direct connection with patients, Dr. Asa is a consultant to several patient groups. Dr. Asa has served as President of the Endocrine Pathology Society (1997–1998) and the US-Canadian Academy of Pathology (2005-6).
Dr. Asa was the keynote speaker at the 2010 Pathology Visions conference where she delivered an eye-opening presentation about the direction of pathology. Her talk clearly illustrated the advantages of digital pathology and gave interesting insights into ways this emerging and powerful technology allows for more specialization among pathologists and improved patient care. “Clinicians want increasingly detailed, reliable and relevant information from specimen analyses that can be translated into optimal treatments. Pathology must re-educate and re-invent itself if it is to maintain the central role it plays as the ultimate arbiter of treatment,” said Dr. Asa.
About the DPA
Formed in 2009, the mission of the Digital Pathology Association is to facilitate education and awareness of digital pathology applications in healthcare. Members are encouraged to share best practices and promote the use of the technology among colleagues in order to demonstrate efficiencies, awareness, and its ultimate benefits to patient care. For additional information about sponsorship and membership opportunities, visit the Digital Pathology Association website.
If you would like more information, please contact Michael F. Ward at (317) 816-1619 or email email@example.com.